US Stock MarketDetailed Quotes

SLNO Soleno Therapeutics

Watchlist
  • 46.7100
  • +0.4300+0.93%
Close Dec 13 16:00 ET
  • 47.4100
  • +0.7000+1.50%
Post 20:01 ET
2.01BMarket Cap-16.74P/E (TTM)

Soleno Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-135.72%-14.93M
-217.12%-17.65M
-86.21%-12.53M
-20.01%-24.94M
-22.77%-6.31M
-36.00%-6.33M
-20.48%-5.57M
-5.75%-6.73M
25.17%-20.78M
25.06%-5.14M
Net income from continuing operations
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
22.14%-24.07M
-93.99%-5.49M
Operating gains losses
----
----
----
706.67%182K
-47,100.00%-470K
32,750.00%653K
----
----
94.09%-30K
100.72%1K
Depreciation and amortization
2.04%500K
1.02%494K
0.00%490K
-0.31%1.96M
0.20%489K
-0.41%490K
-0.61%489K
-0.41%490K
0.05%1.96M
-0.81%488K
Other non cash items
-9.20%987K
320.20%1.71M
19.34%469K
819.19%3.04M
318.86%1.15M
432.84%1.09M
-40.99%406K
149.81%393K
4.74%-422K
83.90%-525K
Change In working capital
5,526.53%5.51M
-598.64%-4.04M
1,600.88%1.94M
487.30%2.93M
852.96%1.91M
-1.01%98K
127.81%811K
111.90%114K
34.15%-756K
83.62%-253K
-Change in prepaid assets
-189.38%-101K
579.55%299K
124.25%81K
-840.71%-837K
-194.64%-660K
3,666.67%113K
-80.00%44K
-392.98%-334K
181.29%113K
50.88%-224K
-Change in payables and accrued expense
525.61%2.43M
-887.93%-4.83M
195.19%3.87M
192.12%1.54M
225.83%190K
-38.35%-570K
467.07%613K
238.62%1.31M
-177.32%-1.68M
80.57%-151K
-Change in other current liabilities
769.37%1.93M
-50.34%-436K
-208.70%-100K
640.43%762K
372.32%738K
40.51%222K
-835.48%-290K
2,966.67%92K
-10.16%-141K
0.00%-271K
-Change in other working capital
278.08%1.26M
107.88%923K
-100.10%-1.91M
54.17%1.46M
316.54%1.64M
-4.86%333K
32.93%444K
-633.85%-954K
441.88%947K
585.19%393K
Cash from discontinued investing activities
Operating cash flow
-135.72%-14.93M
-217.12%-17.65M
-86.21%-12.53M
-20.01%-24.94M
-22.77%-6.31M
-36.00%-6.33M
-20.48%-5.57M
-5.75%-6.73M
25.17%-20.78M
25.06%-5.14M
Investing cash flow
Cash flow from continuing investing activities
4.04M
-120.92M
-115.24M
0
0
0
0
0
40.91%-13K
53.85%-6K
Net PPE purchase and sale
---191K
---8K
---11K
--0
--0
--0
--0
--0
40.91%-13K
53.85%-6K
Net investment purchase and sale
--4.23M
---120.91M
---115.23M
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--4.04M
---120.92M
---115.24M
--0
--0
--0
--0
--0
40.91%-13K
53.85%-6K
Financing cash flow
Cash flow from continuing financing activities
-94.23%2.28M
795.36%152.75M
938K
1,177.46%180.02M
123.56M
11,420.76%39.4M
6,149.65%17.06M
0
11,109.38%14.09M
0
Net common stock issuance
-122.18%-637K
----
----
877.15%137.86M
--117.93M
739.77%2.87M
----
----
--14.11M
--0
Proceeds from stock option exercised by employees
-92.03%2.91M
--3.16M
--938K
--42.16M
--5.63M
--36.53M
--0
--0
--0
--0
Net other financing activities
----
----
----
----
----
----
----
----
86.67%-16K
--0
Cash from discontinued financing activities
Financing cash flow
-94.23%2.28M
795.36%152.75M
--938K
1,177.46%180.02M
--123.56M
11,420.76%39.4M
6,149.65%17.06M
--0
11,109.38%14.09M
--0
Net cash flow
Beginning cash position
194.42%57.02M
444.16%42.85M
1,062.04%169.68M
-31.46%14.6M
165.49%52.44M
-19.52%19.37M
-72.82%7.87M
-31.46%14.6M
-56.72%21.3M
-29.92%19.75M
Current changes in cash
-126.04%-8.61M
23.34%14.18M
-1,785.17%-126.83M
2,413.92%155.08M
2,377.02%117.24M
866.55%33.07M
334.14%11.49M
-187.72%-6.73M
76.00%-6.7M
25.17%-5.15M
End cash Position
-7.67%48.41M
194.42%57.02M
444.16%42.85M
1,062.04%169.68M
1,062.04%169.68M
165.49%52.44M
-19.52%19.37M
-72.82%7.87M
-31.46%14.6M
-31.46%14.6M
Free cash flow
-138.74%-15.12M
-217.27%-17.66M
-86.37%-12.54M
-19.94%-24.94M
-22.63%-6.31M
-36.00%-6.33M
-20.29%-5.57M
-5.75%-6.73M
25.18%-20.79M
25.12%-5.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -135.72%-14.93M-217.12%-17.65M-86.21%-12.53M-20.01%-24.94M-22.77%-6.31M-36.00%-6.33M-20.48%-5.57M-5.75%-6.73M25.17%-20.78M25.06%-5.14M
Net income from continuing operations -605.42%-76.62M-157.86%-21.85M-156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M22.14%-24.07M-93.99%-5.49M
Operating gains losses ------------706.67%182K-47,100.00%-470K32,750.00%653K--------94.09%-30K100.72%1K
Depreciation and amortization 2.04%500K1.02%494K0.00%490K-0.31%1.96M0.20%489K-0.41%490K-0.61%489K-0.41%490K0.05%1.96M-0.81%488K
Other non cash items -9.20%987K320.20%1.71M19.34%469K819.19%3.04M318.86%1.15M432.84%1.09M-40.99%406K149.81%393K4.74%-422K83.90%-525K
Change In working capital 5,526.53%5.51M-598.64%-4.04M1,600.88%1.94M487.30%2.93M852.96%1.91M-1.01%98K127.81%811K111.90%114K34.15%-756K83.62%-253K
-Change in prepaid assets -189.38%-101K579.55%299K124.25%81K-840.71%-837K-194.64%-660K3,666.67%113K-80.00%44K-392.98%-334K181.29%113K50.88%-224K
-Change in payables and accrued expense 525.61%2.43M-887.93%-4.83M195.19%3.87M192.12%1.54M225.83%190K-38.35%-570K467.07%613K238.62%1.31M-177.32%-1.68M80.57%-151K
-Change in other current liabilities 769.37%1.93M-50.34%-436K-208.70%-100K640.43%762K372.32%738K40.51%222K-835.48%-290K2,966.67%92K-10.16%-141K0.00%-271K
-Change in other working capital 278.08%1.26M107.88%923K-100.10%-1.91M54.17%1.46M316.54%1.64M-4.86%333K32.93%444K-633.85%-954K441.88%947K585.19%393K
Cash from discontinued investing activities
Operating cash flow -135.72%-14.93M-217.12%-17.65M-86.21%-12.53M-20.01%-24.94M-22.77%-6.31M-36.00%-6.33M-20.48%-5.57M-5.75%-6.73M25.17%-20.78M25.06%-5.14M
Investing cash flow
Cash flow from continuing investing activities 4.04M-120.92M-115.24M0000040.91%-13K53.85%-6K
Net PPE purchase and sale ---191K---8K---11K--0--0--0--0--040.91%-13K53.85%-6K
Net investment purchase and sale --4.23M---120.91M---115.23M----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow --4.04M---120.92M---115.24M--0--0--0--0--040.91%-13K53.85%-6K
Financing cash flow
Cash flow from continuing financing activities -94.23%2.28M795.36%152.75M938K1,177.46%180.02M123.56M11,420.76%39.4M6,149.65%17.06M011,109.38%14.09M0
Net common stock issuance -122.18%-637K--------877.15%137.86M--117.93M739.77%2.87M----------14.11M--0
Proceeds from stock option exercised by employees -92.03%2.91M--3.16M--938K--42.16M--5.63M--36.53M--0--0--0--0
Net other financing activities --------------------------------86.67%-16K--0
Cash from discontinued financing activities
Financing cash flow -94.23%2.28M795.36%152.75M--938K1,177.46%180.02M--123.56M11,420.76%39.4M6,149.65%17.06M--011,109.38%14.09M--0
Net cash flow
Beginning cash position 194.42%57.02M444.16%42.85M1,062.04%169.68M-31.46%14.6M165.49%52.44M-19.52%19.37M-72.82%7.87M-31.46%14.6M-56.72%21.3M-29.92%19.75M
Current changes in cash -126.04%-8.61M23.34%14.18M-1,785.17%-126.83M2,413.92%155.08M2,377.02%117.24M866.55%33.07M334.14%11.49M-187.72%-6.73M76.00%-6.7M25.17%-5.15M
End cash Position -7.67%48.41M194.42%57.02M444.16%42.85M1,062.04%169.68M1,062.04%169.68M165.49%52.44M-19.52%19.37M-72.82%7.87M-31.46%14.6M-31.46%14.6M
Free cash flow -138.74%-15.12M-217.27%-17.66M-86.37%-12.54M-19.94%-24.94M-22.63%-6.31M-36.00%-6.33M-20.29%-5.57M-5.75%-6.73M25.18%-20.79M25.12%-5.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data